We’re thrilled to announce that SOMAÍ Pharmaceuticals will be joining us as a Silver Sponsor of Cannabis Europa London, 2023.
SOMAÍ Pharmaceuticals is a manufacturer of cannabinoid formulations for the European markets and is committed to revolutionising healthcare through cannabis-based treatments. SOMAÍ is home to a state-of-the-art facility in Lisbon, Portugal, which is equipped with the latest technology and staffed by a team of industry experts who use their knowledge to create the most effective active ingredients. With a clear vision for creating innovative pharmaceutical products from cannabis, SOMAÍ have mastered every aspect of the formulation and manufacturing process, producing medical cannabis treatments that are stable, consistent, and meet the highest pharmaceutical standards. The innovative drug delivery methods at SOMAÍ can ensure widely accessible treatments and they are constantly improving products and services to provide their customers with the best care. As a leader in the medical cannabis and healthcare industry, SOMAÍ takes pride in delivering tailored solutions that improve quality of life, and their commitment to customer service and satisfaction is unmatched.
On becoming a Silver Sponsor for Cannabis Europa London 2023, a spokesperson for SOMAÍ said,
“SOMAÍ Pharmaceuticals is happy to be a Silver Partner on Cannabis Europa. SOMAÍ Pharmaceuticals is a Portuguese manufacturer of cannabinoid formulations for the European markets. At SOMAÍ, we are committed to revolutionising healthcare through cannabis-based treatments. We present medical cannabis products with improved excipient and fast-acting formulations for enhanced bioavailability and pharmacokinetics. We have a wide variety of THC/CBD products that encourage patient adherence and compliance:- APIs;- Oral Drops;- Oral Sprays;- Vape Oil Cartridges;- Soft Gel Capsules;- Sublingual Strips;- Transdermal Patches. By offering a degree of delivery methods, we are able to provide greater flexibility and choice, ultimately leading to improved patient outcomes. Our product launch is in the second half of 2023, so stay tuned! If you want to learn more about our medical cannabis products, check out our catalogue here: lnk.bio/s/somaipharma/dd1ea. We’d love to meet with you at Cannabis Europa!”